Selank Source

Sources · the literature

Selank references: every cited study, listed in full

The complete source list behind the claims on this site, with PubMed and DOI links.

Back to the researchRead the effects page

About this source list

Every numbered citation used across this site appears below in full, with PubMed IDs and DOIs where available. The list reflects the concentration noted throughout the digest: many entries are from Russian research groups and Russian-language journals with English abstracts, and several lack DOIs because of their publication venue. They are listed exactly as catalogued so a reader can locate each source directly. This is a reading list of the published Selank literature, not an endorsement of any claim within it.

Cited literature

The full, numbered reference list with linked PubMed and DOI identifiers is rendered from the site's citation index below. Each entry corresponds to a bracketed [N] citation used on the index, effects, research, dosage, comparison, half-life, and FAQ pages.

  1. Vyunova TV, Andreeva L, Shevchenko K, Myasoedov N. Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity. Protein and Peptide Letters. 2018;25(10):914-923. ↗
  2. Zozulya AA, Kost NV, Sokolov OYu, et al. The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity. Bulletin of Experimental Biology and Medicine. 2001;131(4):315-317. ↗
  3. Inozemtseva LS, Karpenko EA, Dolotov OV, et al. Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo. Doklady Biological Sciences. 2008;421:241-243. ↗
  4. Volkova A, Shadrina M, Kolomin T, et al. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Frontiers in Pharmacology. 2016;7:31. ↗
  5. Uchakina ON, Uchakin PN, Miasoedov NF, et al. Immunomodulatory effects of selank in patients with anxiety-asthenic disorders. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2008;108(5):71-75. ↗
  6. Zozulia AA, Neznamov GG, Siuniakov TS, et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic medication (selank) in the therapy of generalized anxiety disorders and neurasthenia. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2008;108(4):38-48. ↗
  7. Kasian A, Kolomin T, Andreeva L, et al. Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats. Behavioural Neurology. 2017;2017:5091027. ↗
  8. Semenova TP, Kozlovskaya MM, Zuikov AV, et al. Use of Selank to correct measures of integrative brain activity and the level of biogenic amines. Neuroscience and Behavioral Physiology. 2008;38(2):203-207. ↗
  9. Narkevich VB, Kudrin VS, Klodt PM, et al. Effects of heptapeptide selank on the content of monoamines and their metabolites in the brain of BALB/c and C57Bl/6 mice. Eksperimental'naia i Klinicheskaia Farmakologiia. 2008;71(5):8-12. ↗
  10. Semenova TP, Kozlovskii II, Zakharova NM, et al. Comparison of the effects of selank and tuftsin on the metabolism of serotonin in the brain of rats. Eksperimental'naia i Klinicheskaia Farmakologiia. 2009;72(4):6-8. ↗
  11. Slominsky PA, Shadrina MI, Kolomin TA, et al. Peptides Semax and Selank Affect the Behavior of Rats with 6-OHDA Induced Parkinsonism. Doklady Biological Sciences. 2017;474(1):106-109. ↗
  12. Vasil'eva EV, Kondrakhin EA, Salimov RM, et al. Comparison of Pharmacological Effects of Heptapeptide Selank After Intranasal and Intraperitoneal Administration. Eksperimental'naia i Klinicheskaia Farmakologiia. 2016;79(9):3-11. ↗
  13. Kozlovskii II, Belozertsev IuF, Semenova TP, et al. Compensatory effect of selank on the mnestic functions disturbed by neurotoxin MPTP in rats. Eksperimental'naia i Klinicheskaia Farmakologiia. 2008;71(2):3-7. ↗
  14. Kozlovskii II, Belozertsev FIu, Andreeva LA, et al. Protective effect of selank on the model of mnestic function violation induced by MPTP in rats. Eksperimental'naia i Klinicheskaia Farmakologiia. 2013;76(12):3-7. ↗
  15. Pavlov TS, Sanzhieva LTs, Samonina GE, et al. Effect of new synthetic anxiolytic selank on gastric wall blood flow and protective properties of gastric mucosa. Rossiiskii Fiziologicheskii Zhurnal imeni I.M. Sechenova. 2005;91(2):178-183. ↗
  16. Medvedev VE, Tereshchenko ON, Kost NV, et al. Optimization of the treatment of anxiety disorders with selank. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2015;115(6):33-40. ↗
  17. Fomenko EV, Bobyntsev II, Kryukov AA, et al. Effect of Selank on Functional State of Rat Hepatocytes under Conditions of Immobilization Stress. Bulletin of Experimental Biology and Medicine. 2017;163(4):415-418. ↗
  18. Leonidovna YA, Aleksandrovna SM, Aleksandrovna TA, et al. The Influence of Selank on the Level of Cytokines Under the Conditions of Stressogenic Effect. Current Reviews in Clinical and Experimental Pharmacology. 2021;16(2):162-167. ↗
  19. Ershov FI, Uchakin PN, Uchakina ON, et al. Antiviral activity of immunomodulator Selank in experimental influenza infection. Voprosy Virusologii. 2009;54(5):19-24. ↗